iBX Group, Inc.
iBX Group, Inc. IBXG Peers
See (IBXG) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Specialties Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| IBXG | $0.00 | +0.00% | 39.5K | N/A | -$0.07 | N/A |
| BMXXY | $13.83 | +0.00% | 13.5B | 27.19 | $0.42 | +0.86% |
| EBOSY | $41.94 | +0.00% | 2.4B | 25.68 | $1.83 | +2.76% |
| XVIPY | $5.70 | +4.552715654952077e+29% | 718.2M | N/A | N/A | N/A |
| EBRCZ | $0.55 | +0.00% | 204.4M | -4.57 | -$0.12 | N/A |
| TRXDW | $0.15 | -11.76% | 40.1M | N/A | N/A | N/A |
| NVNBW | $0.53 | +0.00% | 9.3M | -0.27 | -$1.95 | N/A |
| SCIE | $0.00 | +7.987220447284345e+24% | 492.4K | -0.01 | -$0.01 | N/A |
| GWPC | $0.00 | +0.00% | 52K | -0.01 | -$0.01 | N/A |
| OMRX | $0.00 | -0.00% | 47.9K | -0.04 | -$0.02 | N/A |
Stock Comparison
IBXG vs BMXXY Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, BMXXY has a market cap of 13.5B. Regarding current trading prices, IBXG is priced at $0.00, while BMXXY trades at $13.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas BMXXY's P/E ratio is 27.19. In terms of profitability, IBXG's ROE is N/A, compared to BMXXY's ROE of +0.10%. Regarding short-term risk, IBXG and BMXXY have similar daily volatility (0.00).
IBXG vs EBOSY Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, EBOSY has a market cap of 2.4B. Regarding current trading prices, IBXG is priced at $0.00, while EBOSY trades at $41.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas EBOSY's P/E ratio is 25.68. In terms of profitability, IBXG's ROE is N/A, compared to EBOSY's ROE of +0.08%. Regarding short-term risk, IBXG and EBOSY have similar daily volatility (0.00).
IBXG vs XVIPY Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, XVIPY has a market cap of 718.2M. Regarding current trading prices, IBXG is priced at $0.00, while XVIPY trades at $5.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas XVIPY's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to XVIPY's ROE of +0.10%. Regarding short-term risk, IBXG is less volatile compared to XVIPY. This indicates potentially lower risk in terms of short-term price fluctuations for IBXG.
IBXG vs EBRCZ Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, EBRCZ has a market cap of 204.4M. Regarding current trading prices, IBXG is priced at $0.00, while EBRCZ trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas EBRCZ's P/E ratio is -4.57. In terms of profitability, IBXG's ROE is N/A, compared to EBRCZ's ROE of -2.89%. Regarding short-term risk, IBXG and EBRCZ have similar daily volatility (0.00).
IBXG vs TRXDW Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, TRXDW has a market cap of 40.1M. Regarding current trading prices, IBXG is priced at $0.00, while TRXDW trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas TRXDW's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to TRXDW's ROE of -5.59%. Regarding short-term risk, IBXG and TRXDW have similar daily volatility (0.00).
IBXG vs NVNBW Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, NVNBW has a market cap of 9.3M. Regarding current trading prices, IBXG is priced at $0.00, while NVNBW trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas NVNBW's P/E ratio is -0.27. In terms of profitability, IBXG's ROE is N/A, compared to NVNBW's ROE of -0.51%. Regarding short-term risk, IBXG and NVNBW have similar daily volatility (0.00).
IBXG vs SCIE Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, SCIE has a market cap of 492.4K. Regarding current trading prices, IBXG is priced at $0.00, while SCIE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas SCIE's P/E ratio is -0.01. In terms of profitability, IBXG's ROE is N/A, compared to SCIE's ROE of +0.00%. Regarding short-term risk, IBXG and SCIE have similar daily volatility (0.00).
IBXG vs GWPC Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, GWPC has a market cap of 52K. Regarding current trading prices, IBXG is priced at $0.00, while GWPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas GWPC's P/E ratio is -0.01. In terms of profitability, IBXG's ROE is N/A, compared to GWPC's ROE of N/A. Regarding short-term risk, IBXG and GWPC have similar daily volatility (0.00).
IBXG vs OMRX Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, OMRX has a market cap of 47.9K. Regarding current trading prices, IBXG is priced at $0.00, while OMRX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas OMRX's P/E ratio is -0.04. In terms of profitability, IBXG's ROE is N/A, compared to OMRX's ROE of -0.15%. Regarding short-term risk, IBXG and OMRX have similar daily volatility (0.00).
IBXG vs SXHHF Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, SXHHF has a market cap of 38.1K. Regarding current trading prices, IBXG is priced at $0.00, while SXHHF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas SXHHF's P/E ratio is -0.01. In terms of profitability, IBXG's ROE is N/A, compared to SXHHF's ROE of +1.13%. Regarding short-term risk, IBXG and SXHHF have similar daily volatility (0.00).
IBXG vs DGCRF Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, DGCRF has a market cap of 21.5K. Regarding current trading prices, IBXG is priced at $0.00, while DGCRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas DGCRF's P/E ratio is 0.00. In terms of profitability, IBXG's ROE is N/A, compared to DGCRF's ROE of -1.11%. Regarding short-term risk, IBXG is less volatile compared to DGCRF. This indicates potentially lower risk in terms of short-term price fluctuations for IBXG.
IBXG vs BMGP Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, BMGP has a market cap of 12.7K. Regarding current trading prices, IBXG is priced at $0.00, while BMGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas BMGP's P/E ratio is -0.01. In terms of profitability, IBXG's ROE is N/A, compared to BMGP's ROE of -0.50%. Regarding short-term risk, IBXG and BMGP have similar daily volatility (0.00).
IBXG vs KKUR Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, KKUR has a market cap of 8.2K. Regarding current trading prices, IBXG is priced at $0.00, while KKUR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas KKUR's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to KKUR's ROE of N/A. Regarding short-term risk, IBXG is less volatile compared to KKUR. This indicates potentially lower risk in terms of short-term price fluctuations for IBXG.
IBXG vs DMSI Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, DMSI has a market cap of 6.4K. Regarding current trading prices, IBXG is priced at $0.00, while DMSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas DMSI's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to DMSI's ROE of -0.32%. Regarding short-term risk, IBXG and DMSI have similar daily volatility (0.00).
IBXG vs IMRSQ Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, IMRSQ has a market cap of 6.3K. Regarding current trading prices, IBXG is priced at $0.00, while IMRSQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas IMRSQ's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to IMRSQ's ROE of -1.30%. Regarding short-term risk, IBXG and IMRSQ have similar daily volatility (0.00).
IBXG vs STBV Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, STBV has a market cap of 4.7K. Regarding current trading prices, IBXG is priced at $0.00, while STBV trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas STBV's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to STBV's ROE of -1.13%. Regarding short-term risk, IBXG and STBV have similar daily volatility (0.00).
IBXG vs AAXT Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, AAXT has a market cap of 1.6K. Regarding current trading prices, IBXG is priced at $0.00, while AAXT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas AAXT's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to AAXT's ROE of +0.54%. Regarding short-term risk, IBXG and AAXT have similar daily volatility (0.00).
IBXG vs XCRP Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, XCRP has a market cap of 1.5K. Regarding current trading prices, IBXG is priced at $0.00, while XCRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas XCRP's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to XCRP's ROE of -3.49%. Regarding short-term risk, IBXG and XCRP have similar daily volatility (0.00).
IBXG vs OMDD Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, OMDD has a market cap of 310. Regarding current trading prices, IBXG is priced at $0.00, while OMDD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas OMDD's P/E ratio is N/A. In terms of profitability, IBXG's ROE is N/A, compared to OMDD's ROE of N/A. Regarding short-term risk, IBXG and OMDD have similar daily volatility (0.00).
IBXG vs QMED Comparison
IBXG plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, IBXG stands at 39.5K. In comparison, QMED has a market cap of 17. Regarding current trading prices, IBXG is priced at $0.00, while QMED trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
IBXG currently has a P/E ratio of N/A, whereas QMED's P/E ratio is -0.00. In terms of profitability, IBXG's ROE is N/A, compared to QMED's ROE of N/A. Regarding short-term risk, IBXG and QMED have similar daily volatility (0.00).